Sort   by:  
 Page size 
UnknownEffects of enzyme replacement therapy on growth in patients with mucopolysaccharidosis type II.
Not available
S-EPMC3026660 | biostudies-literature
UnknownNatural history of alpha mannosidosis a longitudinal study.
Not available
S-EPMC3691585 | biostudies-literature
UnknownMucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy.
Not available
S-EPMC2234442 | biostudies-literature
UnknownMyeloid/Microglial driven autologous hematopoietic stem cell gene therapy corrects a neuronopathic lysosomal disease.
Not available
S-EPMC3808137 | biostudies-literature
UnknownClinical effect and safety profile of recombinant human lysosomal acid lipase in patients with cholesteryl ester storage disease.
Not available
S-EPMC3728169 | biostudies-literature
TranscriptomicsTranscription profiling of mouse cerebral cortex using two model strains (C57BL/6 and ApoE(-/-) on the C57BL background) upon episode hypoxia treatment
Study the gene expression variation at cerebral cortex using two mouse model strains (C57BL/6 and ApoE(-/-) on the C57BL background) upon episode hypoxia treatment
ORGANISM(S): Mus musculus 
2013-01-30 | E-TIGR-135 | biostudies-arrayexpress
UnknownCapturing phenotypic heterogeneity in MPS I: results of an international consensus procedure.
Not available
S-EPMC3379958 | biostudies-literature
UnknownInvariant natural killer T cells are not affected by lysosomal storage in patients with Niemann-Pick disease type C.
Not available
S-EPMC3461304 | biostudies-literature
UnknownResidual lung abnormality following COVID-19 hospitalisation is characterised by biomarkers of epithelial injury.
Not available
S-EPMC12860639 | biostudies-literature
UnknownClinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study.
Not available
S-EPMC9034855 | biostudies-literature
Sort   by:  
 Page size